Lu]Lu-edotreotide led to statistically significant and clinically meaningful improvements in progression-free survival.
Since our foundation in 1984, we have helped the Department of War (DoW), government agencies, and private industry meet mission goals and gain strategic advantage by innovating and advancing the ...
New! Sign up for our free email newsletter.